* Neuronetics Inc STIM.OQ STIM.O is expected to show a
rise in
quarterly revenue when it reports results on November 8.
* The Malvern Pennsylvania-based company is expected to
report a
8.8% increase in revenue to $15.016 million from $13.8 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. The company's guidance on August 2 2022, for
the period ended September 30, was for revenue between $14.50
million and $15.50 million.
* Refinitiv's mean analyst estimate for Neuronetics Inc is
for a
loss of 42 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $9, above its last closing price of $3.48.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.41 -0.41 -0.39 Beat 5.3
Mar. 31 2022 -0.40 -0.40 -0.41 Missed -2.6
Dec. 31 2021 -0.31 -0.32 -0.29 Beat 8.2
Sep. 30 2021 -0.32 -0.30 -0.31 Missed -2.6
Jun. -0.24 -0.24 -0.29 Missed -20.8
30 2021
Mar. 31 2021 -0.29 -0.31 -0.31 Met 0
Dec. 31 2020 -0.23 -0.24 -0.19 Beat 21.1
Sep. 30 2020 -0.27 -0.28 -0.18 Beat 36
This summary was machine generated November 4 at 19:35 GMT. All
figures in US dollars unless otherwise stated